The UK home secretary announced that as of November 1, specialist doctors will...
- Roche reports sales growth as new drugs ease pressure from biosimilar competition
- AstraZeneca to continue UK investment freeze due to Brexit uncertainty
- The highs and lows of hormone replacement therapy
- Gene and cell therapies: making manufacturing work
- Patient death following CAR-T therapy highlights serious manufacturing issues
How will the UK’s relaxed cannabis regulations impact clinical practice?
The UK home secretary announced that as of November 1, specialist doctors will be given the option to legally prescribe patients cannabis-based products if their patients would benefit from the treatment. This will stop regulations from limiting the disease indications that cannabis-based medicines can be prescribed for, and physicians will no longer need to seek approval from an expert panel for patients to access these medicines.
Determination of Absorption of Isopropyl Myristate in Processing Equipment and Packaging Material by Liquid Extraction and Gas Chromatography
Isopropyl myristate (IPM) is widely used as a penetration enhancer and emollient in topical formulations.
Biopharmaceuticals and Liposomal Formulations
Polymun offers the development of liposomal formulations for all kinds of pharmaceutically active ingredients and vaccine antigens. A broad spectrum of analytical methods has been established for this purpose.
Roche reports sales growth as new drugs ease pressure from biosimilar competition
Swiss pharma company Roche reported 7% year on year increase in sales to CHF42.1bn ($42.5bn) in the first nine months of 2018 as newly launched drugs offset the impact of competition from cheaper biosmililars to its top selling medicines.
The New HOF smartVTS Vial Transfer System
The demand for high-quality loading and unloading systems for freeze-drying systems in the pharmaceutical and biotechnological industries is increasing. HOF fulfils this need with the right innovative answers and the expansion of reliable and high-quality production.
Sepha Multi-Q Leak Testing System
The Sepha Multi-Q is a standalone, multi-functional, non-destructive leak test system that can be used in combination with interchangeable attachments to fit the full range of container types available on the market today.
Trial design should give Dermira’s AD drug a better shot at Phase IIb success
Dermira’s lebrikizumab Phase IIb trial for atopic dermatitis (AD) has a better shot at statistical and clinical significance with the exclusion of corticosteroid, a class of steroid hormone, use. The outcome should be able to beat efficacy results of Roche’s previous proof-of-concept (POC) trial that tested lebrikizumab with corticosteroids and only achieved a 20% difference versus placebo, the inactive drug or treatment used in a clinical trial.
AstraZeneca to continue UK investment freeze due to Brexit uncertainty
Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue its freeze on manufacturing investments in Britain if uncertainty over Brexit continues.
Innovative High Containment Pharmaceutical Sieving System from Russell Finex
Russell Finex and Powder Systems Limited (PSL) have collaborated to combine the Russell Compact Sieve® with a high-containment isolator to make an innovative screening solution for pharmaceutical manufacturers.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.